Table 1.
Type 1 | Type 2 | p value | |
---|---|---|---|
The mean age | 65.73 ± 8.11 years (range: 48–75 years) | 68.36 ± 7.89 years (range: 59–88 years) | p = 0.694 |
The mean duration of symptoms | 1.8 ± 1.78 months (range: 1–11 months) | 1.4 ± 0.99 months (range: 1–5 months) | p = 0.092 |
Postoperative follow-up period | 11.60 ± 7.75 months (range: 6–48 months) | 12,88 ± 10,37 months (range: 6–39 months) | p = 0.516 |
Phacoemulsification and intraocular lens application with PPV | 6 (5.1%) | 6 (9.1%) | p = 0.433 |
Preoperative glaucoma | 6 (5.1%) | 4 (6.1%) | p = 0.599 |
The mean preoperative BCVA (logMAR) | 0.94 ± 0.37 (range: 0.15–1.8) | 1.04 ± 0.43 (range: 0.30–1.8) | p = 0.15 |
The mean postoperative third-month BCVA (logMAR) | 0.83 ± 0.36 (range: 0.10–1.30) | 0.98 ± 0.33 (range: 0.10–1.30) | p < 0.05 |
The mean preoperative MLD | 384.24 ± 173.12 µm (range: 70–1226) | 573.24 ± 185.80 µm (range: 183–971) | p < 0.05 |
The mean preoperative BHD | 924.72 ± 341.58 µm (range: 118–2148) | 1153.58 ± 399.86 µm (range: 401–2303) | p = 0.04 |
The mean preoperative HH | 464.5 ± 92.86 µm (range: 276–934) | 506.67 ± 196.27 µm (range: 308–1506) | p = 0.239 |
Reopening in postoperative period | 3 (2.6%) | 10 (15.2%) | p < 0.005 |
BCVA, best-corrected visual acuity; BHD, basal hole diameter; HH, hole height; logMAR, logarithm of the minimal angle of resolution; MLD, minimum linear diameter; PPV, pars plana vitrectomy.